Sector portfolio · Corporate investor · Germany
BI
Boehringer Ingelheim Venture Fund's Biotech portfolio
Boehringer Ingelheim Venture Fund has backed 29 Biotech startups in rounds we track, $856M between them, shown by the stage each has reached. The best-funded is Promethera Biosciences.
29startups backed
5stages
$856Mraised between them
Series Abiggest stage
Series A
11
Funding by segment
- Series A$242M11
- Pre-seed and seed$162M8
- Series B$244M4
- Stage not reported$40M3
- Series C and later$168M3
Where they are based
- Germany7$147M
- United States6$180M
- Switzerland4$95M
- Belgium3$185M
- France2$134M
- United Kingdom2$7.0M
- Sweden1$33M
- Austria1$4.1M
- China1$14M
Germany
United States
Switzerland
Belgium
France
United Kingdom
Sweden
Austria
ChinaFounded
3Earlier
112
113
14
315
16
217
318
319
220
121
122
223
24
25
26
7 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M4
- $10M to $50M21
- $50M to $250M3
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
22 of 29 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- Germany7
- United States6
- Switzerland4
- Belgium3
- France2
- United Kingdom2
- Sweden1
- Austria1
- China1
Startups by country, 9 countries in all.
Segment by segment
Series A
11 startups · $242M raised
DiogenXDiogenX is a preclinical-stage biotechnology company founded in 2020, based in Marseille, France, with research laboratories in Nice.France$37M
Asgard TherapeuticsAsgard Therapeutics is a privately held biotech company based in Lund, Sweden, founded in 2018 as a spin-off from Lund University.Sweden$33M- ATAelin TherapeuticsAelin engages in the research and development of biotherapeutics that utilizes protein aggregation to induce the functional knockdBelgium$32M
Libra TherapeuticsLibra Therapeutics is a biotechnology company.-$29M
Actym Therapeutics, Inc.Actym Therapeutics, Inc.United States$26M
ArmaGen TechnologiesArmaGen is focused on developing technologies for siRNA delivery across the blood-brain barrier.United States$25M- RRigontecGermany$17M
DopavisionDopavision is a digital health company based in Berlin, founded in 2017.Germany$14M
Pre-seed and seed
8 startups · $162M raised
SRTD BiotechSRTD Biotech GmbH is a biotechnology company based in Jülich, Germany, specializing in the development of RNA-based therapeutics.Germany$35M
Cloverleaf BioCloverleaf Bio is a biotechnology company based in New Haven, Connecticut, founded in 2023.United States$33M
TacalyxTacalyx is a biotech company focused on the discovery and development of novel anti-TACAGermany$28M
EvlaBioEvlaBio AG is a life science startup based in Zürich, Switzerland, founded in 2022.Switzerland$25M
Delonix BioworksDelonix Bioworks is a biotech company based in Shanghai, China, specializing in the development of genetically engineered bacterial vaccines.China$14M
TECregenTECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.Switzerland$13M
STRM.BIOSTRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.United States$8.0M
Rinri TherapeuticsRinri Therapeutics is a biotechnology company developing a novel cell-based therapy.United Kingdom$6.4M
Series B
4 startups · $244M raised
ImCheck TherapeuticsImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.France$97M
OncoMyx TherapeuticsOncoMyx Therapeutics is a biotechnology company based in Phoenix, Arizona, founded in 2018.United States$75M
etherna immunotherapieseTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.Belgium$39M- ATAmal TherapeuticsAmal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.Switzerland$33M
Stage not reported
3 startups · $40M raised
HepaRegeniXHepaRegeniX is developing drugs for treating acute and chronic liver diseases.Germany$34M
smartbaxsmartbax GmbH is a biotechnology startup based in Munich, Germany, founded in 2021 as a spin-off from the Technical University of Munich.Germany$5.5M
Glox TherapeuticsGlox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.United Kingdom$617K
Series C and later
3 startups · $168M raised
- PBPromethera BiosciencesBelgium$115M
STAT-DxSTAT-Dx is focused on the development of near-patient testing products for healthcare professionals.-$29MNBE-TherapeuticsNBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.Switzerland$25M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Boehringer Ingelheim Venture Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioWayra's IT Services portfolio57 startups · $38MSector portfolioWayra's Internet portfolio26 startups · $13MSector portfolioWayra's AI portfolio25 startups · $246MSector portfolioWayra's Fintech portfolio22 startups · $287MSector portfolioWayra's Consumer Apps portfolio22 startups · $8.1MSector portfolioWayra's Advertising & Adtech portfolio18 startups · $8.4M
Raising from investors like Boehringer Ingelheim Venture Fund?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.